Vaccine improves survival in monkey tests.
A vaccine tested at the U.S. NIAID clearly improved the survival of monkeys, a benefit not predicted by T-cell and viral load tests. It was predicted by measurements of memory T cells in the first few months of infection--giving important insights into how HIV disease develops, and how to test HIV vaccines early so that only the best candidates will go into large human trials.